We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$947M
AUM Growth
+$42.3M
Cap. Flow
-$10.1M
Cap. Flow %
-1.07%
Top 10 Hldgs %
37.5%
Holding
265
New
13
Increased
83
Reduced
137
Closed
13

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.48M
2
DHI icon
D.R. Horton
DHI
+$4.76M
3
CSCO icon
Cisco
CSCO
+$4.46M
4
STZ icon
Constellation Brands
STZ
+$4.2M
5
DGX icon
Quest Diagnostics
DGX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 21.18%
2 Healthcare 10.11%
3 Financials 8.69%
4 Consumer Discretionary 6.97%
5 Industrials 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNKB
251
DELISTED
LINKBANCORP
LNKB
$198K 0.02%
33,083
PSEC icon
252
Prospect Capital
PSEC
$1.12B
$93.4K 0.01%
15,063
ALL icon
253
Allstate
ALL
$70.1B
-2,667
Closed -$296K
AMD icon
254
Advanced Micro Devices
AMD
$741B
-2,439
Closed -$239K
ES icon
255
Eversource Energy
ES
$28.4B
-2,612
Closed -$204K
FCEL icon
256
FuelCell Energy
FCEL
$1.57B
-498
Closed -$42.6K
FULT icon
257
Fulton Financial
FULT
$4.73B
-10,856
Closed -$150K
GPN icon
258
Global Payments
GPN
$23.9B
-2,278
Closed -$240K
GS icon
259
Goldman Sachs
GS
$305B
-715
Closed -$234K
HUM icon
260
Humana
HUM
$46.7B
-444
Closed -$216K
IJR icon
261
iShares Core S&P Small-Cap ETF
IJR
$110B
-2,436
Closed -$236K
IWD icon
262
iShares Russell 1000 Value ETF
IWD
$82.2B
-1,335
Closed -$203K
SCHX icon
263
Schwab US Large- Cap ETF
SCHX
$71.3B
-12,417
Closed -$200K
VWO icon
264
Vanguard FTSE Emerging Markets ETF
VWO
$119B
-6,336
Closed -$256K
XLP icon
265
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
-8,140
Closed -$608K

Similar funds

Girard Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Girard Partners held 265 positions worth $947M, up 4.7% from $904M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Girard Partners's Q2 2023 filing shows 13 new, 83 increased, 137 reduced and 13 closed positions. Its largest new stake was Charles River Laboratories: 20,680 shares worth $4.35M. The largest sale was Amgen, an estimated $5.48M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Girard Partners's largest Q2 2023 buy was Charles River Laboratories: 20,680 shares worth $4.35M.
  • Girard Partners added most to Estee Lauder in Q2 2023, an estimated $3.62M increase.
  • Girard Partners's biggest Q2 2023 reduction was Amgen, cutting an estimated $5.48M.
  • Girard Partners fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2023, selling an estimated $608K.
  • Girard Partners's ten largest holdings make up 37% of its $947M portfolio in Q2 2023.
  • Girard Partners opened 13 new positions and closed 13 in Q2 2023.
  • Girard Partners's portfolio value rose 4.7% quarter-over-quarter to $947M.

Based on Girard Partners's 13F filing for Q2 2023, filed 15 Aug 2023.